PUBBLICAZIONI
1: Gori-Savellini G, Valentini M, Cusi MG. Toscana Virus NSs protein inhibits the
induction of type I interferon by interacting with RIG-I. J Virol. 2013 Apr 3.
[Epub ahead of print] PubMed PMID: 23552410.
2: Cusi MG, Gandolfo C, Valentini M, Savellini GG. Seroprevalence of Antibodies
to Sandfly Fever Sicilian Virus in a Sample Population in Tuscany, Italy. Vector
Borne Zoonotic Dis. 2013 Jan 5. [Epub ahead of print] PubMed PMID: 23289397.
3: Zanelli G, Bianco C, Cusi MG. Testicular involvement during Toscana virus
infection: an unusual manifestation? Infection. 2012 Nov 17. [Epub ahead of
print] PubMed PMID: 23160838.
4: Houghton R, Gori Savellini G, Chen H, Stevens Y, Moon J, Morkowski S,
Raychaudhuri S, Valentini M, Cusi MG. Comparison of a new prototype
immunochromatographic assay and a commercial enzyme-linked immunosorbent assay
for the detection of serum antibodies against Toscana virus. J Virol Methods.
2013 Jan;187(1):182-4. doi: 10.1016/j.jviromet.2012.09.015. Epub 2012 Sep 25.
PubMed PMID: 23022418.
5: Amodio E, Cusi MG, Valenti RM, Valentini M, Mammina C, Gori-Savellini G,
Vitale F, Romano N, Goedert JJ, Calamusa G. Immunoglobulin M seropositivity for
Toscana virus in a random population sample in Sicily. Int J Infect Dis. 2012
Aug;16(8):e633-5. doi: 10.1016/j.ijid.2012.04.012. Epub 2012 Jun 21. PubMed PMID:
22726418; PubMed Central PMCID: PMC3604883.
6: Mannucci S, Luzzi A, Carugi A, Gozzetti A, Lazzi S, Malagnino V, Simmonds M,
Cusi MG, Leoncini L, van den Bosch CA, De Falco G. EBV Reactivation and
Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic
Burkitt Lymphoma. Adv Hematol. 2012;2012:149780. doi: 10.1155/2012/149780. Epub
2012 Apr 24. PubMed PMID: 22593768; PubMed Central PMCID: PMC3347697.
7: Botta C, Bestoso E, Apollinari S, Cusi MG, Pastina P, Abbruzzese A,
Sperlongano P, Misso G, Caraglia M, Tassone P, Tagliaferri P, Correale P.
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy
regimen in advanced colorectal cancer patients. J Immunother. 2012
Jun;35(5):440-7. doi: 10.1097/CJI.0b013e31825943aa. PubMed PMID: 22576349.
8: Calamusa G, Valenti RM, Vitale F, Mammina C, Romano N, Goedert JJ,
Gori-Savellini G, Cusi MG, Amodio E. Seroprevalence of and risk factors for
Toscana and Sicilian virus infection in a sample population of Sicily (Italy). J
Infect. 2012 Feb;64(2):212-7. doi: 10.1016/j.jinf.2011.11.012. Epub 2011 Nov 18.
PubMed PMID: 22120113.
9: Amodio E, Valentini M, Gori-Savellini G, Valenti RM, Romano N, Goedert JJ,
Cusi MG. Prevalence of toscana and sicilian phlebovirus antibodies in classic
Kaposi sarcoma case patients and control subjects in sicily. J Infect Dis. 2011
Nov;204(9):1423-6. doi: 10.1093/infdis/jir546. Epub 2011 Sep 7. PubMed PMID:
21900487; PubMed Central PMCID: PMC3182312.
10: Cusi MG, Savellini GG. Diagnostic tools for Toscana virus infection. Expert
Rev Anti Infect Ther. 2011 Jul;9(7):799-805. doi: 10.1586/eri.11.54. Review.
PubMed PMID: 21810052.
11: Cusi MG, Roggi A, Terrosi C, Gori Savellini G, Toti M. Retrospective
diagnosis of West Nile virus infection in a patient with meningoencephalitis in
Tuscany, Italy. Vector Borne Zoonotic Dis. 2011 Nov;11(11):1511-2. doi:
10.1089/vbz.2010.0248. Epub 2011 Jul 14. PubMed PMID: 21756029.
12: Cusi MG, Terrosi C, Kleines M, Schildgen O. RSV and HMPV seroprevalence in
Tuscany (Italy) and North-Rhine Westfalia (Germany) in the winter season
2009/2010. Influenza Other Respi Viruses. 2011 Nov;5(6):380-1. doi:
10.1111/j.1750-2659.2011.00252.x. Epub 2011 Apr 18. PubMed PMID: 21668674.
13: Correale P, Botta C, Cusi MG, Del Vecchio MT, De Santi MM, Gori Savellini G,
Bestoso E, Apollinari S, Mannucci S, Marra M, Abbruzzese A, Aquino A, Turriziani
M, Bonmassar L, Caraglia M, Tagliaferri P. Cetuximab ± chemotherapy enhances
dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly
efficient colon cancer antigen-specific cytotoxic T-cell response in vitro. Int J
Cancer. 2012 Apr 1;130(7):1577-89. doi: 10.1002/ijc.26181. Epub 2011 Aug 16.
PubMed PMID: 21618510.
14: Correale P, Cusi MG, Tagliaferri P. Immunomodulatory properties of anticancer
monoclonal antibodies: is the 'magic bullet' still a reliable paradigm?
Immunotherapy. 2011 Jan;3(1):1-4. doi: 10.2217/imt.10.92. PubMed PMID: 21174549.
15: Ranaldi R, Goteri G, Biagetti S, Cusi MG, Rossini S. Histological description
of the lymphadenopathy related to Toscana virus infection. Report of a case.
Pathol Res Pract. 2011 Mar 15;207(3):197-201. doi: 10.1016/j.prp.2010.07.010.
Epub 2010 Nov 5. PubMed PMID: 21115298.
16: Cusi MG, Martorelli B, Di Genova G, Terrosi C, Campoccia G, Correale P. Age
related changes in T cell mediated immune response and effector memory to
Respiratory Syncytial Virus (RSV) in healthy subjects. Immun Ageing. 2010 Oct
20;7:14. doi: 10.1186/1742-4933-7-14. PubMed PMID: 20961416; PubMed Central
PMCID: PMC2984488.
17: Gori Savellini G, Weber F, Terrosi C, Habjan M, Martorelli B, Cusi MG.
Toscana virus induces interferon although its NSs protein reveals antagonistic
activity. J Gen Virol. 2011 Jan;92(Pt 1):71-9. doi: 10.1099/vir.0.025999-0. Epub
2010 Sep 22. PubMed PMID: 20861320.
18: Cusi MG. Why is influenza virus more risky for pregnant women? Influenza
Other Respi Viruses. 2010 Sep;4(5):247-8. doi: 10.1111/j.1750-2659.2010.00156.x.
PubMed PMID: 20716155.
19: Cusi MG. Editorial: arthropod-borne viruses and emergent viruses. Open Virol
J. 2010 Apr 22;4:7. doi: 10.2174/1874357901004020007. PubMed PMID: 20563284;
PubMed Central PMCID: PMC2887639.
20: Cusi MG, Savellini GG, Zanelli G. Toscana virus epidemiology: from Italy to
beyond. Open Virol J. 2010 Apr 22;4:22-8. doi: 10.2174/1874357901004020022.
PubMed PMID: 20517492; PubMed Central PMCID: PMC2879028.
21: Sastre P, Cusi MG, Manoha C, Schildgen O, Ruiz T, Vela C, Rueda P. Serum
antibody response to respiratory syncytial virus F and N proteins in two
populations at high risk of infection: children and elderly. J Virol Methods.
2010 Sep;168(1-2):170-6. doi: 10.1016/j.jviromet.2010.05.011. Epub 2010 May 19.
PubMed PMID: 20488207.
22: Terrosi C, Olivieri R, Bianco C, Cellesi C, Cusi MG. Age-dependent
seroprevalence of Toscana virus in central Italy and correlation with the
clinical profile. Clin Vaccine Immunol. 2009 Aug;16(8):1251-2. doi:
10.1128/CVI.00376-08. Epub 2009 Jun 24. PubMed PMID: 19553552; PubMed Central
PMCID: PMC2725527.
23: Zehender G, Bernini F, Delogu M, Cusi MG, Rezza G, Galli M, Ciccozzi M.
Bayesian skyline plot inference of the Toscana virus epidemic: a decline in the
effective number of infections over the last 30 years. Infect Genet Evol. 2009
Jul;9(4):562-6. doi: 10.1016/j.meegid.2009.02.007. Epub 2009 Feb 27. PubMed PMID:
19460322.
24: Terrosi C, Di Genova G, Martorelli B, Valentini M, Cusi MG. Humoral immunity
to respiratory syncytial virus in young and elderly adults. Epidemiol Infect.
2009 Dec;137(12):1684-6. doi: 10.1017/S0950268809002593. Epub 2009 Apr 15. PubMed
PMID: 19366492.
25: Fabbiani M, Terrosi C, Martorelli B, Valentini M, Bernini L, Cellesi C, Cusi
MG. Epidemiological and clinical study of viral respiratory tract infections in
children from Italy. J Med Virol. 2009 Apr;81(4):750-6. doi: 10.1002/jmv.21457.
PubMed PMID: 19235872.
26: Correale P, Tagliaferri P, Fioravanti A, Del Vecchio MT, Remondo C,
Montagnani F, Rotundo MS, Ginanneschi C, Martellucci I, Francini E, Cusi MG,
Tassone P, Francini G. Immunity feedback and clinical outcome in colon cancer
patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by
subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin
(GOLFIG-1 Trial). Clin Cancer Res. 2008 Jul 1;14(13):4192-9. doi:
10.1158/1078-0432.CCR-07-5278. PubMed PMID: 18593999.
27: Correale P, Del Vecchio MT, La Placa M, Montagnani F, Di Genova G, Savellini
GG, Terrosi C, Mannucci S, Giorgi G, Francini G, Cusi MG. Chemotherapeutic drugs
may be used to enhance the killing efficacy of human tumor antigen
peptide-specific CTLs. J Immunother. 2008 Feb-Mar;31(2):132-47. doi:
10.1097/CJI.0b013e31815b69c8. PubMed PMID: 18481383.
28: Gori Savellini G, Di Genova G, Terrosi C, Di Bonito P, Giorgi C, Valentini M,
Docquier JD, Cusi MG. Immunization with Toscana virus N-Gc proteins protects mice
against virus challenge. Virology. 2008 Jun 5;375(2):521-8. doi:
10.1016/j.virol.2008.02.006. Epub 2008 Mar 19. PubMed PMID: 18355889.
29: Valentini M, Valassina M, Savellini GG, Cusi MG. Nucleotide variability of
Toscana virus M segment in strains isolated from clinical cases. Virus Res. 2008
Jul;135(1):187-90. doi: 10.1016/j.virusres.2008.01.016. Epub 2008 Mar 18. PubMed
PMID: 18353481.
30: Correale P, Del Vecchio MT, Renieri T, Di Genova G, La Placa M, Remondo C,
Savellini GG, Terrosi C, Zurbriggen R, Amacker M, Francini G, Cusi MG.
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled
with parathyroid hormone-related protein derived peptide vaccine. Cancer Lett.
2008 May 18;263(2):291-301. doi: 10.1016/j.canlet.2008.01.018. Epub 2008 Mar 4.
PubMed PMID: 18291576.
31: Terrosi C, Di Genova G, Savellini GG, Correale P, Blardi P, Cusi MG.
Immunological characterization of respiratory syncytial virus N protein epitopes
recognized by human cytotoxic T lymphocytes. Viral Immunol. 2007
Sep;20(3):399-406. PubMed PMID: 17931110.
32: Terrosi C, Fabbiani M, Cellesi C, Cusi MG. Human bocavirus detection in an
atopic child affected by pneumonia associated with wheezing. J Clin Virol. 2007
Sep;40(1):43-5. Epub 2007 Aug 7. PubMed PMID: 17686654.
33: Scardino A, Alimandi M, Correale P, Smith SG, Bei R, Firat H, Cusi MG, Faure
O, Graf-Dubois S, Cencioni G, Marrocco J, Chouaib S, Lemonnier FA, Jackson AM,
Kosmatopoulos K. A polyepitope DNA vaccine targeted to Her-2/ErbB-2 elicits a
broad range of human and murine CTL effectors to protect against tumor challenge.
Cancer Res. 2007 Jul 15;67(14):7028-36. PubMed PMID: 17638916.
34: Cusi MG. Applications of influenza virosomes as a delivery system. Hum
Vaccin. 2006 Jan-Feb;2(1):1-7. Epub 2006 Jan 12. Review. PubMed PMID: 17012895.
35: Correale P, Cusi MG, Micheli L, Nencini C, Del Vecchio MT, Torino F, Aquino
A, Bonmassar E, Francini G, Giorgi G. Chemo-immunotherapy of colorectal
carcinoma: preclinical rationale and clinical experience. Invest New Drugs. 2006
Mar;24(2):99-110. Review. PubMed PMID: 16502353.
36: Correale P, Del Vecchio MT, Di Genova G, Savellini GG, La Placa M, Terrosi C,
Vestri M, Urso R, Lemonnier F, Aquino A, Bonmassar E, Giorgi G, Francini G, Cusi
MG. 5-fluorouracil-based chemotherapy enhances the antitumor activity of a
thymidylate synthase-directed polyepitopic peptide vaccine. J Natl Cancer Inst.
2005 Oct 5;97(19):1437-45. PubMed PMID: 16204693.
37: Correale P, Cusi MG, Tsang KY, Del Vecchio MT, Marsili S, Placa ML, Intrivici
C, Aquino A, Micheli L, Nencini C, Ferrari F, Giorgi G, Bonmassar E, Francini G.
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus
FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating
factor and interleukin-2 induces strong immunologic and antitumor activity in
metastatic colon cancer patients. J Clin Oncol. 2005 Dec 10;23(35):8950-8. Epub
2005 Aug 1. PubMed PMID: 16061910.
38: Correale P, Cusi MG, Del Vecchio MT, Aquino A, Prete SP, Tsang KY, Micheli L,
Nencini C, La Placa M, Montagnani F, Terrosi C, Caraglia M, Formica V, Giorgi G,
Bonmassar E, Francini G. Dendritic cell-mediated cross-presentation of antigens
derived from colon carcinoma cells exposed to a highly cytotoxic multidrug
regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a
powerful human antigen-specific CTL response with antitumor activity in vitro. J
Immunol. 2005 Jul 15;175(2):820-8. Erratum in: J Immunol. 2005 Nov 1;175(9):6235.
Prete, Salvatore [corrected to Prete, Salvatore Pasquale]. PubMed PMID: 16002679.
39: Cusi MG, Del Vecchio MT, Terrosi C, Savellini GG, Di Genova G, La Placa M,
Fallarino F, Moser C, Cardone C, Giorgi G, Francini G, Correale P.
Immune-reconstituted influenza virosome containing CD40L gene enhances the
immunological and protective activity of a carcinoembryonic antigen anticancer
vaccine. J Immunol. 2005 Jun 1;174(11):7210-6. PubMed PMID: 15905566.
40: Cusi MG, Gori Savellini G, Terrosi C, Di Genova G, Valassina M, Valentini M,
Bartolommei S, Miracco C. Development of a mouse model for the study of Toscana
virus pathogenesis. Virology. 2005 Mar 1;333(1):66-73. PubMed PMID: 15708593.
41: Masiero S, Del Vecchio C, Gavioli R, Mattiuzzo G, Cusi MG, Micheli L, Gennari
F, Siccardi A, Marasco WA, Palù G, Parolin C. T-cell engineering by a chimeric
T-cell receptor with antibody-type specificity for the HIV-1 gp120. Gene Ther.
2005 Feb;12(4):299-310. PubMed PMID: 15496956.
42: Cusi MG, Terrosi C, Savellini GG, Di Genova G, Zurbriggen R, Correale P.
Efficient delivery of DNA to dendritic cells mediated by influenza virosomes.
Vaccine. 2004 Jan 26;22(5-6):735-9. PubMed PMID: 14741166.
43: Valassina M, Cusi MG, Valensin PE. A Mediterranean arbovirus: the Toscana
virus. J Neurovirol. 2003 Dec;9(6):577-83. Review. PubMed PMID: 14602570.
44: Scardino A, Correale P, Firat H, Pellegrini M, Kosmatopoulos K, Opolon P,
Alves P, Zurbriggen R, Glück R, Lemonnier FA, Francini G, Cusi MG. In vivo study
of the GC90/IRIV vaccine for immune response and autoimmunity into a novel
humanised transgenic mouse. Br J Cancer. 2003 Jul 7;89(1):199-205. PubMed PMID:
12838324; PubMed Central PMCID: PMC2394210.
45: Valassina M, Valentini M, Pugliese A, Valensin PE, Cusi MG. Serological
survey of Toscana virus infections in a high-risk population in Italy. Clin Diagn
Lab Immunol. 2003 May;10(3):483-4. PubMed PMID: 12738655; PubMed Central PMCID:
PMC154978.
46: Correale P, Aquino A, Giuliani A, Pellegrini M, Micheli L, Cusi MG, Nencini
C, Petrioli R, Prete SP, De Vecchis L, Turriziani M, Giorgi G, Bonmassar E,
Francini G. Treatment of colon and breast carcinoma cells with 5-fluorouracil
enhances expression of carcinoembryonic antigen and susceptibility to
HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro. Int J
Cancer. 2003 Apr 20;104(4):437-45. Erratum in: Int J Cancer. 2003 Jul
20;105(6):882. PubMed PMID: 12584740.
47: Francini G, Scardino A, Kosmatopoulos K, Lemonnier FA, Campoccia G, Sabatino
M, Pozzessere D, Petrioli R, Lozzi L, Neri P, Fanetti G, Cusi MG, Correale P.
High-affinity HLA-A(*)02.01 peptides from parathyroid hormone-related protein
generate in vitro and in vivo antitumor CTL response without autoimmune side
effects. J Immunol. 2002 Nov 1;169(9):4840-9. PubMed PMID: 12391194.
48: Cusi MG, Zurbriggen R, Correale P, Valassina M, Terrosi C, Pergola L,
Valensin PE, Glück R. Influenza virosomes are an efficient delivery system for
respiratory syncytial virus-F antigen inducing humoral and cell-mediated
immunity. Vaccine. 2002 Oct 4;20(29-30):3436-42. PubMed PMID: 12297388.
49: Valassina M, Valentini M, Valensin PE, Cusi MG. Fast duplex one-step RT-PCR
for rapid differential diagnosis of entero- or toscana virus meningitis. Diagn
Microbiol Infect Dis. 2002 Jul;43(3):201-5. PubMed PMID: 12106953.
50: Correale P, Sabatino M, Cusi MG, Micheli L, Nencini C, Pozzessere D, Petrioli
R, Aquino A, De Vecchis L, Turriziani M, Prete SP, Sanguedolce R, Rausa L, Giorgi
G, Francini G. In vitro generation of cytotoxic T lymphocytes against
HLA-A2.1-restricted peptides derived from human thymidylate synthase. J
Chemother. 2001 Oct;13(5):519-26. PubMed PMID: 11760216.
51: Correale P, Cusi MG, Sabatino M, Micheli L, Pozzessere D, Nencini C, Valensin
PE, Petrioli R, Giorgi G, Zurbriggen R, Gluck R, Francini G. Tumour-associated
antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse
model, induced by TAA-plasmids delivered by influenza virosomes. Eur J Cancer.
2001 Nov;37(16):2097-103. PubMed PMID: 11597390.
52: Cusi MG, Correale P, Valassina M, Sabatino M, Valensin PE, Donati M, Glück R.
Comparative study of the immune response in mice immunized with four live
attenuated strains of mumps virus by intranasal or intramuscular route. Arch
Virol. 2001 Jul;146(7):1241-8. PubMed PMID: 11556703.
53: Cusi MG. The response to plasmid DNA-virosome vaccination: a role for
circulating antibodies? Trends Immunol. 2001 Jul;22(7):355. PubMed PMID:
11460824.
54: Correale P, Campoccia G, Tsang KY, Micheli L, Cusi MG, Sabatino M, Bruni G,
Sestini S, Petrioli R, Pozzessere D, Marsili S, Fanetti G, Giorgi G, Francini G.
Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in
cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2. results from a
phase Ib clinical trial. Eur J Cancer. 2001 May;37(7):892-902. PubMed PMID:
11313178.
55: Dionisio D, Valassina M, Ciufolini MG, Vivarelli A, Esperti F, Cusi MG,
Marchi A, Mazzoli F, Lupi C. Encephalitis without meningitis due to sandfly fever
virus serotype toscana. Clin Infect Dis. 2001 Apr 15;32(8):1241-3. Epub 2001 Mar
27. PubMed PMID: 11283818.
56: Valassina M, Migliorini L, Sansoni A, Sani G, Corsaro D, Cusi MG, Valensin
PE, Cellesi C. Search for Chlamydia pneumoniae genes and their expression in
atherosclerotic plaques of carotid arteries. J Med Microbiol. 2001
Mar;50(3):228-32. PubMed PMID: 11232767.
57: Cusi MG, Fischer S, Sedlmeier R, Valassina M, Valensin PE, Donati M, Neubert
WJ. Localization of a new neutralizing epitope on the mumps virus
hemagglutinin-neuraminidase protein. Virus Res. 2001 Apr;74(1-2):133-7. PubMed
PMID: 11226581.
58: Cusi MG, Valensin PE, Donati M, Valassina M. Neutralization of Toscana virus
is partially mediated by antibodies to the nucleocapsid protein. J Med Virol.
2001 Jan;63(1):72-5. PubMed PMID: 11130891.
59: Cusi MG, Zurbriggen R, Valassina M, Bianchi S, Durrer P, Valensin PE, Donati
M, Glück R. Intranasal immunization with mumps virus DNA vaccine delivered by
influenza virosomes elicits mucosal and systemic immunity. Virology. 2000 Nov
10;277(1):111-8. PubMed PMID: 11062041.
60: Valassina M, Cusi MG, Corsaro D, Cellesi C. Chlamydia pneumoniae viability in
atherosclerotic tissue: true or false? J Infect Dis. 2000 Nov;182(5):1577-9.
PubMed PMID: 11023490.
61: Cusi MG, Lomagistro MM, Valassina M, Valensin PE, Glück R. Immunopotentiating
of mucosal and systemic antibody responses in mice by intranasal immunization
with HLT-combined influenza virosomal vaccine. Vaccine. 2000 Jun
15;18(25):2838-42. PubMed PMID: 10812227.
62: Cusi MG, Glück R. Potential of DNA vaccines delivered by influenza virosomes.
Vaccine. 2000 Feb 14;18(15):1435. PubMed PMID: 10733439.
63: Valassina M, Meacci F, Valensin PE, Cusi MG. Detection of neurotropic viruses
circulating in Tuscany: the incisive role of Toscana virus. J Med Virol. 2000
Jan;60(1):86-90. PubMed PMID: 10568768.
64: Cusi MG, Bianchi S, Santini L, Donati D, Valassina M, Valensin PE, Cioé L,
Mazzocchio R. Peripheral neuropathy associated with anti-myelin basic protein
antibodies in a woman vaccinated with rubella virus vaccine. J Neurovirol. 1999
Apr;5(2):209-14. PubMed PMID: 10321986.
65: Soldateschi D, dal Maso GM, Valassina M, Santini L, Bianchi S, Cusi MG.
Laboratory diagnosis of Toscana virus infection by enzyme immunoassay with
recombinant viral nucleoprotein. J Clin Microbiol. 1999 Mar;37(3):649-52. PubMed
PMID: 9986827; PubMed Central PMCID: PMC84506.
66: Cusi MG, Santini L, Bianchi S, Valassina M, Valensin PE. Nucleotide sequence
at position 1081 of the hemagglutinin-neuraminidasegene in wild-type strains of
mumps virus is the most relevant marker of virulence. J Clin Microbiol. 1998
Dec;36(12):3743-4. PubMed PMID: 9867495; PubMed Central PMCID: PMC105283.
67: Valassina M, Soldateschi D, Dal Maso GM, Santini L, Bianchi S, Valensin PE,
Cusi MG. Diagnostic potential of Toscana virus N protein expressed in Escherichia
coli. J Clin Microbiol. 1998 Nov;36(11):3170-2. Erratum in: J Clin Microbiol 1999
Apr;37(4):1237. PubMed PMID: 9774559; PubMed Central PMCID: PMC105295.
68: Valassina M, Cuppone AM, Bianchi S, Santini L, Cusi MG. Evidence of Toscana
virus variants circulating in Tuscany, Italy, during the summers of 1995 to 1997.
J Clin Microbiol. 1998 Jul;36(7):2103-4. PubMed PMID: 9650974; PubMed Central
PMCID: PMC104990.
69: Valassina M, Cuppone AM, Cusi MG, Valensin PE. Rapid detection of different
RNA respiratory virus species by multiplex RT-PCR: application to clinical
specimens. Clin Diagn Virol. 1997 Nov;8(3):227-32. PubMed PMID: 9406653.
70: Valassina M, Cusi MG, Valensin PE. Rapid identification of Toscana virus by
nested PCR during an outbreak in the Siena area of Italy. J Clin Microbiol. 1996
Oct;34(10):2500-2. Erratum in: J Clin Microbiol 1997 May;35(5):1293. PubMed PMID:
8880508; PubMed Central PMCID: PMC229303.
71: Cusi MG, Bianchi S, Valassina M, Santini L, Arnetoli M, Valensin PE. Rapid
detection and typing of circulating mumps virus by reverse
transcription/polymerase chain reaction. Res Virol. 1996 Jul-Aug;147(4):227-32.
PubMed PMID: 8837230.
72: Cusi MG, Bianchi S, Valassina M, Santini L, Valensin PE. Cloning and
sequencing of the F gene of live attenuated Urabe Am9 mumps virus. Gene. 1995 Aug
19;161(2):297-8. PubMed PMID: 7665098.
73: Cusi MG, Valassina M, Bianchi S, Wunner W, Valensin PE. Evaluation of rubella
virus E2 and C proteins in protection against rubella virus in a mouse model.
Virus Res. 1995 Aug;37(3):199-208. PubMed PMID: 8533457.
74: Valassina M, Cusi MG, Corsaro D, Buffi C, Piazzesi G, Valensin PE. Detection
by multiplex polymerase chain reaction and typing of Chlamydia trachomatis
isolates. FEMS Microbiol Lett. 1995 Aug 1;130(2-3):205-9. PubMed PMID: 7649442.
75: Cusi MG, Valassina M, Valensin PE. Comparison of M-MLV reverse transcriptase
and Tth polymerase activity in RT-PCR of samples with low virus burden.
Biotechniques. 1994 Dec;17(6):1034-6. PubMed PMID: 7532975.
76: Cusi MG, Bianchi S, Cioè L, Valensin PE. Expression of recombinant E2 and C
proteins of rubella virus in insect cells. Arch Virol. 1994;137(1-2):35-41.
PubMed PMID: 7979996.
77: Cusi MG, Valensin PE, Cellesi C. Possibility of reinfection after
immunisation with RA27/3 live attenuated rubella virus. Arch Virol.
1993;129(1-4):337-40. PubMed PMID: 8470956.
78: Cusi MG, Cioé L, Rovera G. PCR amplification of GC-rich templates containing
palindromic sequences using initial alkali denaturation. Biotechniques. 1992
Apr;12(4):502-4. PubMed PMID: 1503748.
79: Cusi MG, Valensin PE, Tollis M, Bracci L, Petreni S, Soldani P. Binding
properties of monoclonal antibodies to rabies virus. Microbiologica. 1991
Jul;14(3):205-11. PubMed PMID: 1921740.
80: Cusi MG, Rossolini GM, Valensin PE, Cellesi C, Zanchi A. Serological evidence
of reinfection among vaccinees during rubella outbreak. Lancet. 1990 Oct
27;336(8722):1071. PubMed PMID: 1977047.
81: Lozzi L, Rustici M, Corti M, Cusi MG, Valensin PE, Bracci L, Santucci A,
Soldani P, Spreafico A, Neri P. Structure of rubella E1 glycoprotein epitopes
established by multiple peptide synthesis. Arch Virol. 1990;110(3-4):271-6.
PubMed PMID: 1690535.
82: Valensin PE, Bianchi Bandinelli ML, Cusi MG, Rossolini GM, Zazzi M.
Biotechnology for virus vaccine design, production, and control. J Chemother.
1989 Jul;1(4 Suppl):1069-71. Review. PubMed PMID: 16312775.
83: Cusi MG, Metelli R, Valensin PE. Immune responses to wild and vaccine rubella
viruses after rubella vaccination. Arch Virol. 1989;106(1-2):63-72. PubMed PMID:
2764728.
84: Bracci L, Antoni G, Cusi MG, Lozzi L, Niccolai N, Petreni S, Rustici M,
Santucci A, Soldani P, Valensin PE, et al. Antipeptide monoclonal antibodies
inhibit the binding of rabies virus glycoprotein and alpha-bungarotoxin to the
nicotinic acetylcholine receptor. Mol Immunol. 1988 Sep;25(9):881-8. PubMed PMID:
3062388.
85: Valensin PE, Cusi MG, Zanchi A, Rossolini GM, Cellesi C, Amato T. Rubella
epidemiology over a 14-year period in Siena (Italy): a retrospective serological
survey. Microbiologica. 1988 Apr;11(2):119-27. PubMed PMID: 3405097.
86: Pozzi G, Musmanno RA, Renzoni EA, Oggioni MR, Cusi MG. Host-vector system for
integration of recombinant DNA into chromosomes of transformable and
nontransformable streptococci. J Bacteriol. 1988 Apr;170(4):1969-72. PubMed PMID:
2832394; PubMed Central PMCID: PMC211061.
87: Cellesi C, Rossolini A, Rossolini GM, Bianchi Bandinelli ML, Cusi MG, Egisto
Valensin P. [Evaluation of the specific immune response after anti-rubella
vaccination]. Quad Sclavo Diagn. 1988 Jan-Dec;24(1-4):97-105. Italian. PubMed
PMID: 3268925.
88: Cusi MG, Rossolini GM, Cellesi C, Valensin PE. Antibody response to wild
rubella virus structural proteins following immunization with RA 27/3 live
attenuated vaccine. Arch Virol. 1988;101(1-2):25-33. PubMed PMID: 3046563.
89: Valensin PE, Rossolini GM, Cusi MG, Zanchi A, Cellesi C, Rossolini A.
Specific antibody patterns over a two-year period after rubella immunization with
RA 27/3 live attenuated vaccine. Vaccine. 1987 Dec;5(4):289-94. PubMed PMID:
3433917.
90: Cusi MG, Valensin PE, Barberi A, Guglielmetti P, Rossolini A. Viral childhood
gastroenteritis. Microbiologica. 1986 Oct;9(4):471-8. PubMed PMID: 3022113.
91: Cellesi C, Bandinelli ML, Cusi MG, Di Cairano ML, Valensin PE, Barberi A,
Rossolini A. Rubella in teenagers: epidemiology and prophylaxis in Siena, Italy.
J Biol Stand. 1985 Oct;13(4):283-93. PubMed PMID: 4055805.